Global Clinical Trials for Alzheimer's Disease

1st Edition

Design, Implementation, and Standardization

Print ISBN: 9780124114647
eBook ISBN: 9780124115309
Imprint: Academic Press
Published Date: 18th September 2013
Page Count: 432
75.95 + applicable tax
60.99 + applicable tax
99.95 + applicable tax
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Global Clinical Trials for Alzheimer’s Disease is a handy one-stop reference for researchers and physicians planning and conducting global clinical trials in this area. This book addresses important considerations that may arise during the successful design and execution of these trials, including site selection, local regulatory issues, pharmacogenomics, ethical matters and much more. Given the saturation of traditional clinical trial markets and the worldwide progression of Alzheimer’s disease, there is a need to focus on clinical trials in emerging markets and developing countries. This book provides you with a practical approach to recognizing the opportunities and tackling the challenges that are present during the planning and execution of global clinical trials for Alzheimer’s disease.

Key Features

  • Written by leading experts with hands-on experience in designing and running global Alzheimer’s disease and other neurodegenerative diseases clinical trials
  • A step-by-step guide that provides critical information on the design, conduct and standardization necessary to effectively execute clinical trials and accelerate drug development in this area
  • Includes practical examples, ethical considerations, lessons learned and other valuable tools to aid the planning and implementation of Alzheimer’s disease global clinical trials in emerging markets and developing countries


Targets those individuals worldwide who are involved in clinical trials in AD, dementia and other neurodegenerative diseases, including scientists, physicians, regulators, safety officers, biostatisticians, data managers and more who plan and execute Alzheimer’s Disease clinical trials in and for developing companies.

Table of Contents

Section I – Global Alzheimer’s Disease Clinical Trials

Ch 1 – Introduction and Overview of Global Clinical Trials

Ch 2 – Dementia and Neurodegenerative Diseases: Global and Local Public Health Burden

Section II – Challenges and Opportunities to conduct Alzheimer’s Disease Trials

Ch 3 – Global Issues in Drug Development

Ch 4 – Patient Populations and Evolution of Diagnostic and Therapeutic Standards

Ch 5 – Opportunities for Standardization of Diagnostic and Outcome Measures

Section III – Operationalization of Global Alzheimer’s Disease Trials

Ch 6 - The Increasing Competition for Clinical Trial Sites and Traditional Markets – Issues and Opportunities

Section IV – Enhancing Low and Middle Income Countries Capacities

Ch 7 – Strengthening/Building AD Global Clinical Trial Sites – Lessons Learned

Section V – Pharmacogenomics and Ethical Considerations

Ch 8 – Definitions

Ch 9 – Pharmacogenomics in Clinical Trials

Ch 10 – Pharmacogenomics in AD Clinical Trials

Ch 11 – Conduct of Global Clinical Trials in Vulnerable Populations (Ethical Considerations)

Ch 12 – Next Steps Towards Global Clinical Trials of CNS Disease

Section VI – Human Resources Planning

Ch 13 – Talent Management

Section VII – Appendices

Ch 14 – Useful Online Appendices


No. of pages:
© Academic Press 2014
Academic Press
eBook ISBN:
Hardcover ISBN:


"Written and edited by internationally recognized clinician-scientists, this useful book is a welcome addition to the field…This is a practical and useful reference for conducting international clinical trials in Alzheimer's disease. Researchers that are planning and conducting global clinical trials would benefit from having access to this excellent reference." Rating: 3, April 11, 2014